# Century Therapeutics

Source: https://onco.cc/companies/century-therapeutics/  
OnCo record `century-therapeutics` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Century makes off-the-shelf cell therapies from induced pluripotent stem cells that are engineered to hide from the patient's immune system. Its main focus is now type 1 diabetes, with a CD19 CAR T-like product for cancer and autoimmune disease due to enter the clinic in 2026.

## Summary

Century Therapeutics develops allogeneic, induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune disease and cancer. Lead programme CNTY-813 is an iPSC-derived islet replacement therapy for type 1 diabetes with an IND submission planned for the fourth quarter of 2026 following a pre-IND meeting with the FDA. CNTY-308 is a CD19-targeted CAR-iT (iPSC-derived T cell) therapy incorporating the company's Allo-Evasion 5.0 immune-evasion edits, on track to enter the clinic in 2026. The company reported $197.2 million in cash and investments at 30 June 2026 with runway into the first quarter of 2029. Century is headquartered in Philadelphia and trades on Nasdaq as IPSC.

## Fields

- Kind: Company
- Last checked: 2026-09-10
- HQ: Philadelphia, PA
- Type: cell-therapy
- Website: https://www.centurytx.com/
- Ticker: IPSC

## Notes

- Strategic emphasis has shifted to type 1 diabetes; oncology exposure is via CNTY-308 (CD19 CAR-iT). IPO round not sourced (June 2021 8-K did not state proceeds).

## Sources

- Official website: https://www.centurytx.com/
- Q2 2026 results (8-K exhibit 99.1): https://www.sec.gov/Archives/edgar/data/1850119/000110465926094533/tm2622911d1_ex99-1.htm

## Connected records

- fronts: [Cell Therapy](https://onco.cc/fronts/cell-therapy/)
- technologies: [Allogeneic (off-the-shelf) cell therapy](https://onco.cc/technologies/allogeneic-cell-therapy/), [Allogeneic cell banks: one donor, hundreds of doses](https://onco.cc/technologies/allogeneic-cell-banks/), [CAR-T cell therapy](https://onco.cc/technologies/car-t/)
- targets: [CD19](https://onco.cc/targets/cd19/)
- companies: [Leaps by Bayer](https://onco.cc/companies/leaps-by-bayer/)

---
JSON: https://onco.cc/api/v1/entities/century-therapeutics.json